Diagnostic value of plasma circular RNA based on droplet digital polymerase chain reaction in lung adenocarcinoma.

Wanying Sun, Changming Zhou, Caiqiu Peng, Ran Yang, Mengting Li, Jian Geng, Jihong Zhou, Liang Chen, Wei Li
{"title":"Diagnostic value of plasma circular RNA based on droplet digital polymerase chain reaction in lung adenocarcinoma.","authors":"Wanying Sun, Changming Zhou, Caiqiu Peng, Ran Yang, Mengting Li, Jian Geng, Jihong Zhou, Liang Chen, Wei Li","doi":"10.1093/labmed/lmad101","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Plasma circular (circ)RNAs detected by droplet digital polymerase chain reaction (ddPCR) may be ideal markers for liquid biopsy. However, ddPCR detection of circRNAs in plasma for diagnosis of lung adenocarcinoma has been rarely reported.</p><p><strong>Methods: </strong>An RNA sequencing analysis was performed in plasma from patients with early lung adenocarcinoma and healthy individuals. Droplet digital PCR was used to verify the differentially expressed genes.</p><p><strong>Results: </strong>The copy numbers of circle RNALZIC (circLZIC)and circle RNACEP350 (circCEP350) in the plasma of lung adenocarcinoma patients were significantly higher than in plasma of healthy people, and the copy numbers in postoperative plasma of the same patients were significantly lower than those in preoperative plasma. CircLZIC and circCEP350 alone and in combination had diagnostic value in lung adenocarcinoma and early lung adenocarcinoma. CircLZIC and circCEP350 had more binding sites with multiple microRNAs. Their target genes were enriched in several signaling pathways.</p><p><strong>Conclusion: </strong>The copy numbers of circLZIC and circCEP350 were higher in plasma of lung adenocarcinoma patients than in plasma of healthy controls, significantly correlated with tumor size and TNM stage, and closely related to the occurrence and development of tumors. These circRNAs may serve as molecular markers for the diagnosis of lung adenocarcinoma.</p>","PeriodicalId":94124,"journal":{"name":"Laboratory medicine","volume":" ","pages":"420-432"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/labmed/lmad101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Plasma circular (circ)RNAs detected by droplet digital polymerase chain reaction (ddPCR) may be ideal markers for liquid biopsy. However, ddPCR detection of circRNAs in plasma for diagnosis of lung adenocarcinoma has been rarely reported.

Methods: An RNA sequencing analysis was performed in plasma from patients with early lung adenocarcinoma and healthy individuals. Droplet digital PCR was used to verify the differentially expressed genes.

Results: The copy numbers of circle RNALZIC (circLZIC)and circle RNACEP350 (circCEP350) in the plasma of lung adenocarcinoma patients were significantly higher than in plasma of healthy people, and the copy numbers in postoperative plasma of the same patients were significantly lower than those in preoperative plasma. CircLZIC and circCEP350 alone and in combination had diagnostic value in lung adenocarcinoma and early lung adenocarcinoma. CircLZIC and circCEP350 had more binding sites with multiple microRNAs. Their target genes were enriched in several signaling pathways.

Conclusion: The copy numbers of circLZIC and circCEP350 were higher in plasma of lung adenocarcinoma patients than in plasma of healthy controls, significantly correlated with tumor size and TNM stage, and closely related to the occurrence and development of tumors. These circRNAs may serve as molecular markers for the diagnosis of lung adenocarcinoma.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于液滴数字聚合酶链反应的血浆环状RNA诊断肺腺癌的价值。
背景:用液滴数字聚合酶链反应(ddPCR)检测血浆环状rna可能是液体活检的理想标记物。然而,利用ddPCR检测血浆环状rna诊断肺腺癌的报道很少。方法:对早期肺腺癌患者和健康人的血浆进行RNA测序分析。采用微滴数字PCR对差异表达基因进行验证。结果:肺腺癌患者血浆中环状RNALZIC (circLZIC)和环状RNACEP350 (circCEP350)拷贝数显著高于健康人血浆,同一患者术后血浆中环状RNACEP350拷贝数显著低于术前血浆。CircLZIC和circCEP350单独或联合应用对肺腺癌和早期肺腺癌具有诊断价值。CircLZIC和circCEP350与多个microrna的结合位点较多。它们的靶基因在多种信号通路中富集。结论:肺腺癌患者血浆中circLZIC和circCEP350拷贝数高于健康对照组,且与肿瘤大小、TNM分期显著相关,与肿瘤的发生发展密切相关。这些环状rna可作为肺腺癌诊断的分子标记物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparison of basic lymphocyte phenotype results between a diagnostic and a research laboratory. Evidence-based approach for the generation of a multivariate logistic regression model that predicts instrument failure. Correlation of the abundance of MDSCs, Tregs, PD-1, and PD-L1 with the efficacy of chemotherapy and prognosis in gastric cancer. Correction to: The utility of an algorithm based on procalcitonin monitoring in patients with sepsis. Implementing laboratory internal audit to improve compliance and quality of care in the municipal public health system-based ambulatory care health clinics in New York city.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1